Gynecologic VHealth V3rd
VEdition(2023 Vverified Vby Vexperts)
VBy VSchuiling Vand VLikis
[Authorvname]
V[COMPANYvNAME]v V[Companyvaddress
]
,6/20/23, V 3:54 Womens V Gynecologic V Health V 3rd V Edition
VP V Schuiling
1
Women’s V Gynecologic V Health, VThird VEdition
Test VBank
1
about:blank 1/120
,6/20/23, V 3:54 Womens V Gynecologic V Health V 3rd V Edition
VP V Schuiling
2
CHAPTER V 1 V QUESTIONS
MULTIPLE-CHOICE V QUESTIONS
Select V thevone V correct V answer V to V each V ofvthe V following V questions.
1. Which V of V the V following V best V defines V the V term V “gender” V as V used V in V this
V text?
a. A V person‟s V sex
b. A V person‟s V sex V as V defined V by V society
c. A V societal V response V to V a V person‟s V self-representation V as V a V man V or
V woman
d. A V person‟s V biological V presentation V as V defined V by V himself V or V herself
2. Which V factor V bears V most V on V women‟s V health V care V today?
a. The V complexity V ofvwomen‟s V health
b. Women‟s V status V and V position V in V society
c. Population V growth
d. The V economy
3. Why V is V acknowledging V the V oppression V of V women V more
V difficult V within V Western Vsocieties?
a. The V multiplicity V ofvminority V groups V complicates V the V issue.
b. The V availability V ofvhealth V care V makes V acknowledgment V more V difficult.
c. The V diversity V of V the V news V media V clouds V the V issue.
d. Affluence V and V increased V opportunities V mask V oppression.
4. Which V of V the V following V most V accurately V defines V “oppression” V as V used V in
V the V text?
a. Not V having V a V choice
b. Not V having V a V voice
c. An V actvofvtyranny
d. A V feeling V of V being V burdened
5. In V what V way V does V a V model V of V care V based V on V a
V feminist V perspective V contrast V s V harply V with Va V biomedical
V model?
a. It V provides V a V forum V for V the V exploration V of V gender V issues.
b. It V seeks V equal V distribution V ofvpower V within V the V healthcare V interaction.
c. It V emphasizes V women‟s V rights.
d. It V opens V new V avenues V for V women‟s V health V care.
6. Gender V is V rooted V in and V shaped V by .
a. society, V biology
b. self-representation, V societal V expectations
c. biology, V environment V and V experience
2
about:blank 2/120
, 6/20/23, V 3:54 Womens V Gynecologic V Health V 3rd V Edition
VP V Schuiling
3
d. biology, V hormones
7. Women‟s V health V risks, V treatments, V and V approaches V are V not
V always V based V in V sci V ence V and Vbiology V because
a. they V are V often V based V on V outdated V treatments V and V approaches.
b. they V are V determined V by V social V expectations V and V gender V assumptions.
c. they V often V rely V on V alternative V treatments V and V approaches.
d. scientific V research V often V fails V to V take V women V into V consideration.
8. Reproductive V rights V were V added V to V the V World V Health
V Organization‟s V huma V n V rights Vframework V in V the V last ?
a. 5 V years
b. 10 V years
c. 20 V years
d. 40 V years
9. “Safe V Motherhood” V was V added V to V the V human V rights V framework V in V order
V to
a. address V maternal V morbidity V and V mortality V on V a V global V level
b. meet V a V legal V obligation
c. correct V an V injustice
d. correct V an V oversight
10. What V is V a V chief V failing V ofvthe V biomedical V model V in V regards V to V women‟s
V health V care?
a. Its V reliance V on V studies V comprised V exclusively V of V males
b. Its V consideration V ofvwomen V as V central V the V model
c. Its V emphasis V on V science V and V medicine
d. Its V limited V definition V of V “health” V as V “the V absence V of V disease”
11. The V social V model V ofvhealth V places V the V focus V ofvhealth V on
a. the V community.
b. the V individual.
c. environmental V conditions.
d. scientific V research.
12. Which V question V below V supports V the V strategy: V “Identify
V women‟s V agency V in V t V he V midst Vofvsocial V constraint V and
V the V biomedical V paradigm.”?
a. “Are V „all V women‟ V the V same?”
b. “Why V do V youvcare V about V the V issue?”
c. “Are V women V really V victims V or V are V they V acting V with V agency?”
d. “Who V has V avchoice V within V the V context V of V health?”
13. What V had V been V a V significant V problem V in V medical V research V well V into V the
V 1990s?
a. The V focus V on V randomized V clinical V trials V over V epidemiological V investigations
b. The V lack V of V representation V ofvwomen V in V research V trials
c. The V lack V of V research V related V to V gynecology
d. The V focus V on V randomized V clinical V trials V over V observational V research
3
about:blank 3/120